Published On: Wed, Oct 19th, 2016

Analysts At Mizuho Securities Reiterated Unitedhealth Group Inc. (NYSE:UNH) As Buy

Today analysts at Mizuho Securities reiterated Unitedhealth Group Inc.’s (NYSE:UNH) shares as ‘Buy’ in a report released to investors.

According to Mizuho Securitiess price target of 169 on the company’s stock this indicates the broker now believes there is an increase of 16.61% from Unitedhealth Group Inc.’s current price of 144.93.


In the last year Unitedhealth Group Inc.’s stock price has increased by 22.17% from 118.63 to 144.93.

The number of Unitedhealth Group Inc. shares in issue is 952,391,000 which have a current share price of 144.93 bringing Unitedhealth Group Inc.’s market capitalisation to 138.03B USD.

The 52 week high of shares in Unitedhealth Group Inc. is 145 while the 52 week low for the company’s shares is 107.51. The businesses 50 day moving average is 137.12 and its 200 day moving average is 136.75.

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. UnitedHealthcare provides healthcare benefits to an array of customers and markets, and includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, and UnitedHealthcare Global businesses. Optum is a health services business serving the healthcare marketplace, including payers, care providers, employers, governments, life sciences companies and consumers, through its OptumHealth, OptumInsight and OptumRx businesses. OptumInsight provides services, technology and healthcare solutions to participants in the healthcare industry. OptumRx provides retail network contracting, purchasing and clinical solutions.